Technical Analysis for ATBPF - Antibe Therapeutics

Grade Last Price % Change Price Change
B 4.3214 -5.85% -0.2686
ATBPF closed down 5.85 percent on Tuesday, February 23, 2021, on 1.58 times normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Up Down
Historical ATBPF trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup -5.85%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -5.85%
Wide Bands Range Expansion -5.85%
Down 3 Days in a Row Weakness -5.85%
Calm After Storm Range Contraction -11.08%
Older End-of-Day Signals for ATBPF ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Antibe Therapeutics Description

Antibe is a commercial-stage pharmaceutical company focused on pain, inflammation and regenerative medicine. Antibe's lead drug, ATB-346, targets the global need for a safer non-steroidal anti-inflammatory drug ('NSAID') for treating chronic pain and inflammation with non-addictive medication. Antibe's subsidiary, Citagenix Inc. ('Citagenix'), is a leader in Canada in the sales and marketing of tissue regenerative products servicing the dental and orthopaedic marketplaces. Since its inception in 1997, Citagenix has become an important source of knowledge and experience in the Canadian medical device industry. Citagenix has grown a comprehensive portfolio of high-quality, branded biologics and medical devices that promote bone regeneration. Citagenix is active in 15 countries, operating in Canada through its direct sales teams, and internationally via a network of distributor partnerships.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Sciences Pharmaceutical Pain Medication Inflammation Regenerative Medicine Chronic Pain Hepatotoxins Nonsteroidal Anti Inflammatory Drugs Anti Inflammatory

Is ATBPF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.88
52 Week Low 2.21
Average Volume 47,967
200-Day Moving Average 0.0000
50-Day Moving Average 3.4016
20-Day Moving Average 3.9302
10-Day Moving Average 4.7658
Average True Range 0.3574
ADX 36.62
+DI 39.6649
-DI 29.7047
Chandelier Exit (Long, 3 ATRs ) 4.8078
Chandelier Exit (Short, 3 ATRs ) 3.8522
Upper Bollinger Band 5.7118
Lower Bollinger Band 2.1486
Percent B (%b) 0.61
BandWidth 90.6621
MACD Line 0.4529
MACD Signal Line 0.4108
MACD Histogram 0.0421
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.0887
Resistance 3 (R3) 5.1629 4.9815 4.9608
Resistance 2 (R2) 4.9815 4.7861 4.9443 4.9181
Resistance 1 (R1) 4.6514 4.6654 4.5607 4.5772 4.8755
Pivot Point 4.4700 4.4700 4.4246 4.4328 4.4700
Support 1 (S1) 4.1399 4.2746 4.0492 4.0657 3.7673
Support 2 (S2) 3.9585 4.1539 3.9213 3.7247
Support 3 (S3) 3.6284 3.9585 3.6820
Support 4 (S4) 3.5542